Multicenter evaluation of Xpert HIV‐1 viral load assay for HIV quantification in China
- 11 July 2020
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 92 (12) , 3295-3300
Abstract
New approaches to increase HIV‐1 testing and HIV‐1 viral load (VL) monitoring are needed for people living with HIV (PLHIV) in China. The Xpert HIV‐1 VL assay was prequalified by the World Health Organization in 2017 but has not been evaluated in China. A multicenter evaluation was conducted to assess the accuracy of the Cepheid Xpert HIV‐1 VL assay compared to the Abbott RealTime HIV‐1 assay in China. Overall agreement was seen in 558 of 562 specimens (99.29%) with a κ value of 0.962. Pearson's coefficient between the two assays was 0.943. Analyzed by the Bland‐Altman method, the mean bias was −0.54 log10 copies/mL, and 94.05% results fell within the 95% confidence limit of agreement (−1.248 to 0.168 log10 copies/mL). The coefficient of variation of the Cepheid Xpert HIV‐1 VL assay ranged from 0.61% to 1.55%, as determined by testing eight positive plasma specimens with three different lots on different days. Due to its simplicity, random‐access, rapid turnaround time, and accuracy, the Xpert HIV‐1 VL assay can be used in local hospitals and clinics that bear the burden of identifying and treating HIV patients in China.Keywords
This publication has 21 references indexed in Scilit:
- Point-of-care HIV testing can help achieve UNAIDS targetsThe Lancet HIV, 2020
- Point-of-care HIV viral load testing combined with task shifting to improve treatment outcomes (STREAM): findings from an open-label, non-inferiority, randomised controlled trialThe Lancet HIV, 2020
- Global, regional and country-level 90–90–90 estimates for 2018AIDS, 2019
- The growing threat of China's HIV epidemicThe Lancet Public Health, 2018
- Scaling Up Human Immunodeficiency Virus Screening and Antiretroviral Therapy Among Men Who Have Sex With Men to Achieve the 90-90-90 Targets in ChinaSexually Transmitted Diseases, 2018
- Increase Access to Timely and Periodic Viral Load Testing to Achieve the 90-90-90 Targets for Human Immunodeficiency Virus in ChinaClinical Infectious Diseases, 2018
- Point-of-Care Cepheid Xpert HIV-1 Viral Load Test in Rural African Communities Is Feasible and ReliableJournal of Clinical Microbiology, 2016
- Diagnostic point-of-care tests in resource-limited settingsThe Lancet Infectious Diseases, 2014
- Viral Load Monitoring as a Tool to Reinforce AdherenceJAIDS Journal of Acquired Immune Deficiency Syndromes, 2013
- Evaluation of Portable Point-of-Care CD4 Counter with High Sensitivity for Detecting Patients Eligible for Antiretroviral TherapyPLOS ONE, 2012